HPRA Information Update
 

 

The Health Products Regulatory Authority has published the 106th edition of its Drug Safety Newsletter. 

The latest edition includes information on review of the latest evidence on risks associated with in-utero exposure to phenytoin, phenobarbital, carbamazepine, pregabalin and valproate.

For further details please click here.

Rate: 12345 (3) | Facebook Twitter LinkedIn Digg Yammer
In this issue
More Than 76,500 Nurses and Midwives Renew for 2022
NMBI CEO, Sheila McClelland to Give the Keynote Address at the 2022 All-Ireland Maternity and Midwifery Festival
NMBI Board Approves New Requirements for Nurse Registration Programmes
NMBI Welcomes Return of Nightingale Challenge Programme
Decisions Following Fitness to Practise Inquiries
Calls for Abstracts for Major Dublin Advanced Nursing Conference
HSE National Immunisation Office: Covid-19 Vaccine Bulletin
HPRA Information Update
News Round
Board Profile: Mark Blake-Knox, Board Member and Member of the Audit and Risk Committee, and Fitness to Practise Committee (2011)
Update DetailsSend to a friendArchive